THE HALFAX HEIMDALL AUGUR

Alibaba agrees to pay US$600 million to settle US probe into illegal product sales Alibaba Group will pay US$600 million to settle a US Department of Justice investigation into allegations that its e-commerce platforms enabled the sale of thousands of illegal pharmaceuticals, controlled substances, and other prohibited products into the United States, marking one of the largest criminal resolutions involving a Chinese technology company. The settlement, announced on Wednesday, resolves the investigation through non-prosecution agreements with Alibaba and AUS Merchant Services,...

Alibaba to pay US $600M to settle allegations it allowed illegal sales Alibaba has agreed to pay $600 million to settle a dispute with the U.S. government WASHINGTON --TheChinese tech giant Alibabawill pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals, and pill-making equipment into the U.S. Alibaba operates some of the world's largest e-commerce platforms, including Alibaba.com and AliExpress.com. The U.S. alleges that Alibaba’s U.S.-based payment processor, AUS Merchant Services, violated federal law by failing to prevent merchants from selling and importing illegal products into the U.S. through Alibaba.com and AliExpress.com. Alibaba acknowledges inan agreement with the Justice Departmentthat between January 2016 and December 2024, it failed to stop roughly 80,000 product sales involving unlawful imports that violated the Federal Food, Drug, and Cosmetic Act and other federal laws. A news release on the settlement resolution says that Alibaba employees raised concerns that the company’s compliance controls were inadequate and fai…

Alibaba to pay $600m to settle illegal drug sales allegations in US probe E-commerce giant admitted it failed to ⁠prevent 80,000 illegal drug product sales, according to US Justice Department.

Alibaba will pay 600 million dollars to settle a US probe into illegal ... TL;DR Alibaba and its US payment arm will pay 600 million dollars to resolve a DOJ probe into illegal pharmaceutical sales on its e-commerce platform. Alibaba and its US digital payment processor have agreed to pay 600 million dollars to resolve a federal investigation into whether they failed to prevent the sale and importation of illegal pharmaceuticals and controlled substances, the Justice Department said on Wednesday. Alibaba entered into a non-prosecution agreement to end a probe of alleged violations of the Federal Food, Drug, and Cosmetic Act between 2016 and 2024. The investigation was led by the DOJ and the US Attorney’s Office in Rhode Island. Alibaba admitted that overseas customers used its platforms to make roughly 80,000 purchases of products that lacked approvals under US drug, device, or importation laws, with a combined value of more than 200 million dollars. The agreement did not specify the products by name, but the DOJ said they involved pharmaceuticals, regulated chemicals, and drug counterfeiting equipment. US agents conducted more than 40 undercover purchases of drugs and equipment t…

FILE – The logo of Chinese technology firm Alibaba is seen at its office in Beijing, Aug. 10, 2021. (AP Photo/Mark Schiefelbein, File) By Associated Press PUBLISHED: July 1, 2026 at 5:10 PM EDT | UPDATED: July 1, 2026 at 6:12 PM EDT Getting your Trinity Audio player ready... By FATIMA HUSSEIN WASHINGTON (AP) — The Chinese tech giant Alibaba will pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals, and pill-making equipment into the U.S. Alibaba operates some of the world’s largest e-commerce platforms, including Alibaba.com and AliExpress.com. The U.S. alleges that Alibaba’s U.S.-based payment processor, AUS Merchant Services, violated federal law by failing to prevent merchants from selling and importing illegal products into the U.S. through Alibaba.com and AliExpress.com. Alibaba acknowledges in an agreement with the Justice Department that between January 2016 and December 2024, it failed to stop roughly 80,000 product sales involving unlawful imports that violated the Federal Food, Drug, and Cosmetic Act and other federal laws. A news r…

Alibaba agrees to pay $600M to settle federal probe into drug sales Alibaba agrees to pay $600M to settle federal probe into drug sales The Chinese e-commerce giant and its US payment processor will resolve a federal investigation tied to illegal drug sales on its platforms. Share Add us on Google by Editorial Team Jul. 1, 2026 Alibaba Group and its US payment processor have agreed to pay $600 million to settle a federal probe into illegal drug sales facilitated through the company’s platforms. What we know about the settlement The $600 million figure covers both Alibaba and its US-based payment processor, though the specific processor involved has not been publicly identified. The federal investigation centered on illegal drug sales that took place on Alibaba’s marketplace platforms. The specific federal agency or agencies leading the probe have not been officially disclosed. That could mean the DOJ, FDA, DEA, or some combination thereof. Advertisement The settlement does not appear to involve any cryptocurrency or blockchain-related elements, which separates it from the wave of enforcement actions that have dominated financial headlines over the past two years. A pattern, not an…

Crypto Fan (https://cryneo.neocities.org/) 02/07. (https://blockonomi.com/alibaba-baba-reaches-600m-doj-settlement-following-illegal-drug-sales-investigation/) - Alibaba (BABA) Reaches $600M DOJ Settlement Following Illegal Drug Sales Investigation

US: ALIBABA AND PAYMENT PROCESSOR TO PAY $600 MILLION IN DOJ SETTLEMENT OVER ILLEGAL DRUG SALES On 1 July, the Wall Street Journal reported that Alibaba Group and a US-based AUS Merchant Services are to pay $600 million www.wsj.com/business/ali... www.msn.com/en-us/money/...

Alibaba to pay $600M to settle claims of illegal drug sales | AP News The logo of Chinese technology firm Alibaba is seen at its office in Beijing, Aug. 10, 2021. (AP Photo/Mark Schiefelbein, File) WASHINGTON (AP) — TheChinese tech giant Alibabawill pay $600 million to resolve a dispute with the U.S. government over allegations that the Hangzhou-based firm sold and imported illegal pharmaceuticals, controlled substances, regulated chemicals, and pill-making equipment into the U.S. Alibaba operates some of the world’s largest e-commerce platforms, including Alibaba.com and AliExpress.com. The U.S. alleges that Alibaba’s U.S.-based payment processor, AUS Merchant Services, violated federal law by failing to prevent merchants from selling and importing illegal products into the U.S. through Alibaba.com and AliExpress.com. Alibaba acknowledges inan agreement with the Justice Departmentthat between January 2016 and December 2024, it failed to stop roughly 80,000 product sales involving unlawful imports that violated the Federal Food, Drug, and Cosmetic Act and other federal laws. A news release on the settlement resolution says that Alibaba employees raised concerns that the compa…